Classification of clinically actionable genetic mutations in cancer patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shahzad, Muhammad | - |
dc.contributor.author | Rafi, Muhammad | - |
dc.contributor.author | Alhalabi, Wadee | - |
dc.contributor.author | Ali, Naz Minaz | - |
dc.contributor.author | Anwar, Muhammad Shahid | - |
dc.contributor.author | Jamal, Sara | - |
dc.contributor.author | Ali, Muskan Barket | - |
dc.contributor.author | Alqurashi, Fahad Abdullah | - |
dc.date.accessioned | 2024-02-13T00:30:38Z | - |
dc.date.available | 2024-02-13T00:30:38Z | - |
dc.date.issued | 2024-01 | - |
dc.identifier.issn | 2296-889X | - |
dc.identifier.issn | 2296-889X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90391 | - |
dc.description.abstract | Personalized medicine in cancer treatment aims to treat each individual's cancer tumor uniquely based on the genetic sequence of the cancer patient and is a much more effective approach compared to traditional methods which involve treating each type of cancer in the same, generic manner. However, personalized treatment requires the classification of cancer-related genes once profiled, which is a highly labor-intensive and time-consuming task for pathologists making the adoption of personalized medicine a slow progress worldwide. In this paper, we propose an intelligent multi-class classifier system that uses a combination of Natural Language Processing (NLP) techniques and Machine Learning algorithms to automatically classify clinically actionable genetic mutations using evidence from text-based medical literature. The training data set for the classifier was obtained from the Memorial Sloan Kettering Cancer Center and the Random Forest algorithm was applied with TF-IDF for feature extraction and truncated SVD for dimensionality reduction. The results show that the proposed model outperforms the previous research in terms of accuracy and precision scores, giving an accuracy score of approximately 82%. The system has the potential to revolutionize cancer treatment and lead to significant improvements in cancer therapy. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.title | Classification of clinically actionable genetic mutations in cancer patients | - |
dc.type | Article | - |
dc.identifier.wosid | 001148077700001 | - |
dc.identifier.doi | 10.3389/fmolb.2023.1277862 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN MOLECULAR BIOSCIENCES, v.10 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85183017939 | - |
dc.citation.title | FRONTIERS IN MOLECULAR BIOSCIENCES | - |
dc.citation.volume | 10 | - |
dc.type.docType | Article | - |
dc.publisher.location | 스위스 | - |
dc.subject.keywordAuthor | personalized medicine | - |
dc.subject.keywordAuthor | genetic mutations | - |
dc.subject.keywordAuthor | machine learning | - |
dc.subject.keywordAuthor | natural language processing | - |
dc.subject.keywordAuthor | precision medicine | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.